EE143 Cost-Effectiveness of Ofatumumab Compared with Other Disease-Modifying Therapies for the Treatment of Relapsing Multiple Sclerosis in Greece
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.395
https://www.valueinhealthjournal.com/article/S1098-3015(22)02599-2/fulltext
Title :
EE143 Cost-Effectiveness of Ofatumumab Compared with Other Disease-Modifying Therapies for the Treatment of Relapsing Multiple Sclerosis in Greece
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02599-2&doi=10.1016/j.jval.2022.09.395
First page :
Section Title :
Open access? :
No
Section Order :
12201